3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
5
Breast Neoplasms
5
Neoplasm Metastasis
4
Biliary Tract Neoplasms
4
Lung Neoplasms
3
Colorectal Neoplasms
3
Oropharyngeal Neoplasms
2
Neoplastic Cells, Circulating
2
Cholangiocarcinoma
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Uterine Cervical Dysplasia
1
Urinary Bladder Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Sarcoma, Ewing
1
Recurrence
1
Prostatic Neoplasms
1
Papillomavirus Infections
1
Neurofibrosarcoma
1
Neurofibromatosis 1
1
Neurofibroma, Plexiform
1
Neuroectodermal Tumors, Primitive, Peripheral
1
Neoplasm, Residual
1
Hematopoietic and Lymphoid System Neoplasm
1
Gallbladder Neoplasms
1
Colorectal Neoplasms, Hereditary Nonpolyposis
1
Colonic Neoplasms
1
Carcinoma, Lobular
1
Carcinoma, Hepatocellular
1
Interventions
Rituximab
46
Cyclophosphamide
38
ibrutinib
23
fludarabine
22
venetoclax
21
acalabrutinib
21
zanubrutinib
17
Lenalidomide
17
Bendamustine Hydrochloride
17
obinutuzumab
16
fludarabine phosphate
14
Magnetic Resonance Spectroscopy
14
Cytarabine
14
Specimen Handling
13
CT-P10
13
pirtobrutinib
12
Biopsy
12
glofitamab
10
Etoposide
10
Whole-Body Irradiation
9
Vincristine
7
Peripheral Blood Stem Cell Transplantation
7
Mycophenolic Acid
7
Melphalan
7
Doxorubicin
7
brexucabtagene autoleucel
6
Cyclosporine
6
orelabrutinib
5
Methotrexate
5
Immunotherapy, Adoptive
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, Mantle-Cell
×
Liquid Biopsy
×
1 year
×
Clear all
No trials found.